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Reactive oxygen intermediates (ROI) ~ play an essential role in host resistance 
to microbial infection. ROI produced by phagocytic cells after membrane stim- 
ulation (for example, during phagocytosis of bacteria), exert a bactericidal effect 
through both halogenation and direct oxidation of the ingested microbes. The 
importance of ROI in this regard is highlighted in patients with genetic defects 
in neutrophil function, characterized by their inability to produce ROI. In time, 
these patients develop a chronic granulomatous disease (1). Paradoxically, there 
is also evidence to show that ROI, when released extracellularly, may cause tissue 
inflammation and injury (2).  For example, neutrophils stimulated by activated 
complement components or  aggregated  immunoglobulin release  superoxide 
anion  into  the  extracellular  environment (3).  At  the  same  time,  parenteral 
administration of superoxide dismutase, a  scavenger of superoxide anion, has 
been shown to have an antiinflammatory effect (4). 
The alveolar macrophage (AM),  by virtue of its direct exposure to the envi- 
ronment, is generally considered to constitute a "first line of defense" in protect- 
ing the  host against pulmonary infection by inhaled  microorganisms, and  is 
known to produce ROI under certain circumstances (5-9). However, if inhalation 
of  environmental dust capable of  activating macrophages caused an inappropriate 
release of ROI into the alveolar microenvironment, the delicate alveolar tissues 
might be injured. Clearly, the ability to regulate ROI production and/or release 
by AM would be highly advantageous to the host. 
We now report that resident rabbit AM do not normally release ROI into the 
extracellular environment when triggered in vitro by membrane-active agents 
such as phorbol esters (PMA) or concanavalin A (Con A). However, after being 
conditioned by exposure to serum for a period of 24-48 h, AM readily produce 
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and release ROI. This serum-conditioning effect of resident AM is a function of 
both  the  concentration  of serum  used  and  the  duration  of treatment,  and  is 
reversible and inhibitable by cycioheximide. In addition, NADPH oxidase activity 
in resident AM  is markedly increased as a  consequence of serum conditioning. 
This  conditioning  effect appears  to  be  due  to  a  discrete  serum  constituent 
possessing an estimated molecular weight of 30,000-50,000  (30-50 K); it is not 
species  specific  in  its  action  and  it  is  distinct  from  endotoxin  and  gamma 
interferon. 
Materials and Methods 
Animals.  Male  pathogen-free  New  Zealand  White  rabbits  weighing  3-5  lbs  were 
purchased  from  Hazelton  Dutchland  Inc.  (Denver, PA).  The rabbits  were housed  in 
laminar flow rooms supplied with filtered air and were given rabbit chow and water ad 
libitum. 
AM Isolation.  Resident AM were harvested by tracheal lavage according to the method 
of Myrvik (10). Briefly, rabbits were sacrificed by intravenous injection of 75 mg/kg body 
weight of Ketamine HCI (Parke, Davis & Co., Detroit, MI). The lungs from each rabbit 
were cannulated via the trachea and lavaged in situ eight times with 50-ml volumes of 
prewarmed (37 ° C) Hanks' calcium/magnesium-free balanced salt solution. The cells from 
individual  animals  were collected by centrifugation at  40 g  for  10  rain  at  4°C.  Any 
contaminating erythrocytes were lysed by incubating with Tris-buffered NH4C1 for 5 min 
at 37°C. The cells were then washed twice with Hanks' balanced salt solution (HBSS) and 
once with minimum essential medium (MEM) containing 100 U/ml penicillin, 100 #g/ml 
streptomycin, 2 mM L-glutamine, and 1 mM sodium pyruvate. Cell viability was consist- 
ently -95% and, in general, 5-7  ×  107 viable macrophages were obtained from each 
rabbit. The AM cell concentration was adjusted to 1.0 ×  10  6 cells/ml, and 0.5 ml of this 
cell suspension was added to each 16-mm-diam well ofa Linbro tissue culture plate (Linbro 
Scientific Co., Hamden, CT), resulting in 5.0 ×  10  ~ cells/well at a density of 2.5 ×  l0  B 
cells/cm  2. The plates were incubated at 37°C in 5% CO2 to allow adherence of macro- 
phages.  After 2  h  of incubation,  the  monolayers, which  were >99%  macrophages as 
determined by differential staining, were washed with HBSS and reincubated with MEM 
(with or without serum as a conditioning agent) for the desired length of time before 
assaying ROI activity. In lipopolysaccharide (LPS) priming experiments, AM were incu- 
bated for up to 72 h with MEM containing 0.001-1.0 #g/ml LPS before assaying ROI 
activity. Growth factors (Gibeo Laboratories, Grand Island,  NY) used for conditioning 
AM were insulin (5 #g/ml), transferrin (5 #g/ml), epidermal growth factor (100 ng/ml), 
fibroblast growth  factor (100  ng/ml),  hydrocortisone (10  -s  M),  Ts (10  -'°  M),  sodium 
selenite  (10  -8  M),  putrescine  (5  #g/ml),  fibronectin,  and  a  trace  element  mix.  The 
conditioning activity of these  factors was  assayed  after 48  h  of incubation  with  AM 
monolayers. 
Hydrogen Peroxide Assay.  Production of H202 by AM  was quantitated by a  method 
described by Pick and Keisari (11), based on the H~O2-mediated and horseradish peroxi- 
dase (HRP)-dependent oxidation of phenol red, yielding a reaction product that absorbs 
maximally at 610 nm. The phenol red assay solution (PRS) contains 140 mM NaCI,  10 
mM  potassium  phosphate  buffer,  pH  7.0,  5.5  mM  dextrose,  0.28  mM  phenol  red 
(phenolsulfonphthalein, sodium salt; Sigma Chemical Co., St. Louis, MO), and 8.5 U/ml 
HRP (type II, 170 purogallin U/rag solid; Sigma Chemical Co.). To assay H~O2 production 
of the total AM population, including those viable AM that became detached from the 
monolayers during incubation, the culture medium was collected from each well, centri- 
fuged, and any pelleted cells resuspended in  1 ml PRS. A  10 #1 vol of the appropriate 
triggering agent (e.g., Con A) was then added to the PRS containing the nonadherent 
AM, at which point the mixtures were added back to the appropriate wells containing the 
adherent AM, and incubated at 37°C with 5% CO~ for 30 or 90 rain. Controls included 
wells with PRS but no triggering agent and wells with PRS but no cells. At the completion 394  SERUM  CONDITIONING OF  ALVEOLAR  MACROPHAGES 
of incubation, the culture fluids were collected, centrifuged, and the supernatant fluids 
transferred to clean test tubes. The cell-free fluids were made alkaline by the addition of 
10 •1  of 1 N NaOH per tube; the absorbance (610 nm) of each sample was then determined 
against a blank of PRS to which  10 #1 of 1 N  NaOH was added.  Standard curves were 
made, using the same preparation of PRS, with  1-30 #M H202 solutions. The standards 
were treated in the same manner as the experimental cultures. All stimulants and controls 
were tested in triplicate for each rabbit. In some instances, 1,250 U/mi catalase (purified 
powder  from  bovine  liver,  1,860  U/mg  protein;  Sigma  Chemical  Co.)  was  used  to 
specifically inhibit H,O2 accumulation. 
Superoxide Anion Assay.  O~ was measured by the reduction of ferricytochrome c (12). 
Both  the  adherent  and  any  nonadherent  AM  from  individual  wells  were  assayed as 
previously described for the H20~ assay. Briefly, the nonadherent cells from each well 
were harvested in test tubes and resuspended in  1 ml of an 80 t~M solution of ferricyto- 
chrome c (type III; Sigma Chemical Co.) in  HBSS lacking phenol red.  The triggering 
agents (in  10 #1 volume) were added to the tubes, at which time the assay medium was 
added back to the corresponding wells containing adherent cells and the cultures incubated 
for 90 min at 370C in 5% CO2. Controls included AM in cytochrome c solution containing 
HBSS but no added triggering agent, and cultures containing cytochrome c solution and 
triggering agent but no macrophages. Each concentration was tested in triplicate for each 
rabbit.  After  incubation,  the  supernatant  fluids  from each culture  were harvested  by 
centrifugation for 10 min at 1,500 rpm at 4°C, and the absorbance measured at 550 nm 
against blanks consisting of cytochrome c solution (also incubated for 90 min at 370C). 
The amount of cytochrome c reduced was determined by the formula, Es~0 --" 2.1  ×  104 
M  -~  cm -l  (12). The specificity of cytochrome c reduction was assessed by the addition of 
300 U/ml superoxide dismutase (SOD) (type I from bovine blood, 3,000 U/rag protein; 
Sigma Chemical Co.) to some samples. 
pH Stability of Macrophage-conditioning  Activity.  To examine whether the factor(s) in 
serum that conditions  AM  for ROI production  was acid  labile, a  5%  solution of fetal 
bovine serum (FBS)  in  MEM  was adjusted to pH 2.0  with concentrated HCI. The pH- 
adjusted FBS solution and control FBS solution (pH 7.4) were maintained at 4°C for 2 h. 
The pH of the acid-treated FBS solution was then readjusted to 7.4 with 40% saturated 
NaOH and the medium sterilized by passage through a 0.45 #m filter. AM monolayers 
were conditioned with either control or acid-treated medium for 48 h, at which time the 
cells were assayed for their ability to produce H,O, by triggering the cells with 10 tzg/ml 
Con A. 
NADPH Oxidase Assay.  NADPH oxidase activity was assessed by measuring O~ pro- 
duction in deoxycholate (DOC)-treated AM in the presence of exogenous NADPH and 
required  the  use  of acetylated  ferricytochrome  c  to  avoid  detection  of cytochrome 
reductase activity (13). Ferricytochrome c was acetylated by the procedure of Tsunawaki 
and  Nathan  (13),  based  on  the  method  described  by Kakinuma and  Minakami  (14). 
Briefly, 300 mg of ferricytochrome c in 10 ml of half-saturated sodium acetate was slowly 
mixed with acetic anhydride at  100  mol/mol of ferricytochrome c for 40 rain at 0°C, 
followed by 48-h dialysis against distilled water. The efficiency of the acetylated ferricy- 
tochrome c at detecting Og was -50% of native ferricytochrome c. The rate of NADPH 
oxidase-induced O~ production was assayed as described by Tsunawaki and Nathan (13), 
with modifications. Freshly harvested AM, or AM that had been cultured 48 h with or 
without serum containing medium, were incubated 45 min with 10 mM diethyldithiocar- 
bamic acid (DDC) to inhibit endogenous SOD activity. Cells were harvested with a rubber 
policeman,  washed  with  HBSS,  and  suspended  in  1  ml  HBSS  (pH  7.5)  with  30  tzM 
acetylated ferricytochrome c and 2 mM NaNs (to inhibit cytochrome oxidase), at a cell 
concentration of 1-2 ×  106 celis/ml. The suspension was made in a 1 cm light path cuvette 
in the thermostatted (37 ° C) chamber of a spectrophotometer (Gilford Instrument Labo- 
ratories, Inc., Oberlin, OH) set to continuously read absorbance at 550 nm. To initiate 
O~ production, the intact cells were triggered with  1 #g/ml PMA. When the rate of O~ 
formation reached its maximum, the cells were lysed by addition of 0.07% (wt/voi) DOC, 
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c reduction after immediate addition  of NADPH  (type X;  Sigma Chemical Co.) at a 
saturation concentration of 1.2 mM. The addition of 300 U/ml SOD to either the intact 
cells  or lysed cells  completely abolished O~  ferricytochrome c reduction. Activity was 
expressed as nanomoles of acetylated ferricytochrome c reduced per minute per 10~ cells. 
Ammonium Sulfate Precipitation.  As an initial step in isolating the homologous serum 
factor(s) responsible for AM conditioning, pooled rabbit serum (175 ml) was separated 
into two fractions by ammonium sulfate precipitation. A 40% saturation of ammonium 
sulfate was achieved by addition of powdered salt to pooled rabbit serum at 4°C. After 4 
h the precipitated protein was removed by centrifugation and sufficient ammonium sulfate 
added to the supernatant fluid to reach 80% saturation. The precipitable material obtained 
after both steps was redissolved in distilled H~O and then dialyzed against 0.05 M Tris/ 
0.15 M NaCI, pH 8.0. A small portion of each ammonium sulfate cut was also dialyzed 
against MEM and assayed for ROI-conditioning activity. 
Affinity  Chromatography.  After dialysis,  the protein fraction that precipitated at 40- 
80% salt saturation was applied to a 2.5 × 90 cm Cihacron Blue affinity column (Affigel- 
blue; Bio-Rad Laboratories, Richmond, CA), equilibrated with 0.05 M Tris/0.15 M NaC1, 
pH 8.0, at a flow rate of-148 ml]h. Nonbinding proteins were eluted with 0.05 M Tris] 
0.15 M  NaCI, pH  8.0, and binding proteins eluted with 2  M  NaSCN. Aliquots of the 
various fractions (12 ml/tube) were dialyzed against MEM and assayed for their ROI- 
conditioning activity.  Fractions containing activity were  pooled and  concentrated by 
lyophilization. 
Gel Filtration.  The active material from the affinity chromatography step was applied 
to a 2.5 × 60 cm Sephacryl S-200 column (Pharmacia Fine Chemicals, Uppsala, Sweden), 
equilibrated with PBS, pH 7.2, at a flow rate of ~48 ml]h. The column was calibrated 
with bovine serum albumin (66 K tool wt), ovalbumin (45 K), and alpha chymotrypsinogen 
A (25 K). The exclusion volume was determined by using Blue Dextran 2000. Eluted 3- 
ml fractions were dialyzed against MEM and tested for their ROI-conditioning activity. 
Chemicals.  The tissue culture reagents MEM, FBS, HBSS (10×), streptomycin, peni- 
cillin, L-glutamine, and sodium pyruvate were purchased from Gibco Laboratories. NU 
serum, which contains FBS and specific growth factors, was obtained from Collaborative 
Research Inc.,  Lexington, MA.  H~O~ was  purchased from J.  T.  Baker Chemical Co., 
Phillipsburg, N  J, as a 30% solution. Standards were made by initially diluting 1.0 ml of a 
30% solution of H202 in 1,000 ml H20. The actual concentration was determined from 
its absorption at 230 nm, using an extinction coefficient of 81  M  -~ cm  -~ (11). PMA was 
obtained from Sigma Chemical Co. and was diluted in dimethylsulfoxide at 5  mg/ml, 
aliquoted, and stored at -70°C.  Con A (Calbiochem-Behring Corp., La Jolla, CA) was 
obtained at a concentration of 25 mg]ml in 5% sterile glucose, and stored at 4°C. LPS 
(from Escherichia  coli 0128-B12; Difco Laboratories Inc., Detroit, MI) was dissolved in 
H~O at a concentration of 10 mg]ml and stored at 4°C. Cycloheximide (Sigma Chemical 
Co.) was dissolved in distilled H~O at a concentration of 1 mg]ml. DDC (Sigma Chemical 
Co.)  was  dissolved  in  H20  at  a  concentration of  1  M.  Recombinant human  gamma 
interferon (rIFN-3,),  from an E. eoli host recombinant DNA procedure (AMGen Biologi- 
cals, Thousand Oaks, CA) was diluted in 40 mM Tris-HCI, pH 7.5, to a concentration of 
108 U/ml. The activity of this rINF-3, preparation was determined by AMGen Biological 
by assaying its ability to inhibit the cytopathic effect in HeLa cells infected with encephal- 
omycarditis virus. 
Results 
In our initial experiments we found that addition of membrane-active agents, 
such as Con A  or PMA, to freshly harvested rabbit AM resulted in little if any 
incremental release of ROI. However, after these cells had been cultured in vitro 
for 24-48  h  in  the  presence of FBS,  subsequent  addition  of Con  A  or  PMA 
readily  triggered  ROI  release.  The  effectiveness of such  serum  conditioning 
depended upon the concentration of serum used, with maximal ROI production 
after conditioning with an FBS concentration of 7.5% or greater (Fig.  1). 396  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
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FIGURE  1.  Effect of FBS on conditioning AM for H~O= release.  HsO2 release was triggered 
with I 0 #g/ml Con A after incubation of cells for 48 h with medium containing 0-20% FBS. 
Each point  represents  the  mean  of six  values  from  two  rabbits  assayed  in  triplicate.  Bars 
represent the standard error of the mean (SEM). 
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FIGURE 2.  H202 release by AM triggered after 0, 24, 48, and 72 h of incubation in medium 
containing 5% FBS. Each point represents the mean of nine values from three rabbits assayed 
in triplicate (bars indicate SEM). (R) 5.0 #g/ml PMA; (A) 50 #g/ml Con A; (0) 250 #g/ml Con 
A; (O) 10 #g/ml LPS; and (O) 100 #g/ml LPS. 
We next examined the time required to condition rabbit AM for ROI produc- 
tion, using a fixed concentration of FBS (5%). No significant H20~ or O~ release 
was observed unless the cells had been conditioned in serum-containing medium 
for  at  least  24  h,  with  48  h  required  in  most instances  (Figs.  2  and  3).  This 
experiment  also  demonstrated  that  whereas  both  Con  A  and  PMA  readily 
stimulated ROI release from serum-conditioned AM,  LPS stimulated poorly or 
not at all. Using AM conditioned for 48 h in 5% FBS, we determined the optimal 
Con A  concentration  for triggering  ROI release.  Maximal H202 accumulation 
was  triggered  by  10  #g  Con  A/mi,  whereas  maximal  O~"  accumulation  was 
achieved using 50-250 #g Con A/ml (Fig. 4). Similar dose-response studies using 
LPS as a triggering agent (at 1.0 ng/ml to 100 ug/ml) confirmed the inability of 
this agent to trigger ROI release from serum-conditioned AM (data not shown). 
Next, we compared FBS, autologous rabbit serum, pooled human serum, and GERBERICK,  WILLOUGHBY,  AND  WILLOUGHBY  397 
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FIGURE 3.  O~ release by AM triggered after 0, 24, 48, and 72 h of incubation in medium 
containing 5% FBS. Each point represents the mean of nine values from three rabbits assayed 
in triplicate (bars indicate SEM). 01) 5.0 #g/ml PMA; (a) 50 #g/ml Con A; (Q) 250 #g/ml Con 
A; (12) 10 #g/ml LPS; and (O) 100 #g/ml LPS. 
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FIGURE 4.  Con A  triggering of O~  and H~O~ release by AM.  Cells were conditioned in 
medium containing 5% FBS for 48 h, at which time the cells were triggered with Con A. F~ch 
point represents the mean of six values from two rabbits assayed  in triplicate (bars indicate 
SEM). (O) H~O~ values; and ([3) O~- values. 
NU serum (a semidefined serum substitute containing FBS) for their ability to 
condition AM for subsequent ROI production. Each was used at a final concen- 
tration  of 10%,  which preliminary experiments had shown to be optimal.  All 
serum  preparations  conditioned  AM  for  subsequent  ROI  production  upon 
triggering by Con A, with FBS the most effective (Table I). In contrast, neither 
bovine, rabbit, nor human serum albumin proved capable of conditioning AM, 
thus arguing against a simple protein nutrient effect (Table I). Another possible 
explanation for this serum effect would be that  serum supplies  the necessary 398  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
TABLE  I 
Effect of Pretreatment of  AM With Serum or Albumin on H~O~ 
Release 
Exp.  Conditioning agent  H~O2/30 min per 5 
x  105 cells 
nmol 
None  2.1 ±  0.4 
10% Autologous serum  9.5 ±  1.6 
10% NU serum  17.0 ±  2.1 
10% FBS  24.2 ±  0.9 
None  4.2 ±  1.3 
5% FBS  22.5 :~0.1 
10% FBS  21.5 ~= 0.1 
f 
4.0 mg/ml Human albumin  4.0 ±  1.5 
4.0 mg/mi Rabbit albumin  3.1 ±  0.7 
4.0 mg/ml Bovine albumin  3.7 ±  0.6 
None  <0.5 
10% FBS  16.1 ±  0.6 
10% Human serum  9.1 ±  0.9 
AM were cultured 48 h with the indicated conditioning agent, then assayed 
for Con A (10 #g/ml)-stimulated H20, release. Data represent the mean 
of nine values from three rabbits assayed in triplicate _  SEM. 
TABLE  II 
pH Stability of Serum-conditioning Activity 
Conditioning agent  Triggering agent  H202/30 min per 
5 x  10  5 cells 
nmol 
5% FBS  10 ~g/ml Con A  17.1 
5% Acid-treated FBS  10/~g/ml Con A  11.5 
None  10 ~g/ml Con A  1.4 
AM were cultured for 48 h  with MEM containing either 5% FBS or 5% 
acid-treated FBS, then triggered with  10 #g/ml Con A, and assayed for 
H~O~ release. 
growth factor(s) and/or nutrient(s) essential for ROI production. We tested the 
ability of AM to release ROI after preincubation for 48 h with insulin, transferrin, 
epidermal growth factor, fibroblast growth factor, hydrocortisone, progesterone, 
fibronectin, sodium selenite, putrescine-HCl, and a trace element mixture, either 
alone or in a limited number of combinations. In no case did such pretreatment 
condition AM for subsequent ROI production upon stimulation with Con A. 
The ability of monocyte-derived macrophages to release ROI is known to be 
enhanced  by  IFN-3",  a  50  K  moi  wt  glycoprotein  lymphokine  that  is  90% 
inactivated by acid treatment  at pH  2  for 2  h  (15).  As one way to determine 
whether our serum factor could be IFN-3,, we adjusted the pH of a 5% solution 
of FBS in MEM to 2.0, held the pH at 2.0 for 2 h at 4°C, then readjusted it to 
7.4.  When  compared  with control  serum  solutions maintained  at pH  7.4,  the 
acid-treated preparation  was still  active, retaining  67% of its activity (Table II). GERBERICK,  WILLOUGHBY,  AND  WILLOUGHBY  399 
Next, we tested human rIFN-~, for conditioning activity of rabbit AM, since we 
had found that human serum was fully capable of conditioning rabbit AM for 
ROI release (Table I). No activity was detected after incubation of rIFN-~, with 
rabbit AM for 48 h at 0.01-1,000  U/ml (data not shown). 
While LPS does not trigger ROI production by peritoneal macrophages (16, 
17), it has been reported (18) to "prime" such cells, causing them to release ROI 
in enhanced quantities upon subsequent triggering with other membrane-active 
agents. Thus, it seemed possible that the conditioning effect we were observing 
with serum resulted from priming by contaminating endotoxin. Accordingly, we 
precultured AM in medium containing LPS at  1.0 ng/ml to  1.0 #g/ml, but in 
the absence of serum; as positive and negative controls, we cultured other AM 
in the presence of 5% FBS or with serum-free medium, respectively. After 24, 
48, and 72 h  of culture, the cells were triggered with Con A  and assessed for 
ROI production. As expected, cells incubated for 48-72  h  in the presence of 
5% FBS readily released H~O2, while cells incubated in medium alone produced 
little  if any  H~O2.  Cells  incubated  in  the presence of LPS  alone  showed no 
increase in  H~O~  release over that  by media controls (Table  III).  In related 
experiments, we further observed that addition of LPS to FBS failed to augment 
the ability of FBS to condition AM for ROI release (data not shown). 
The reversibility of this serum effect was assessed by incubating aliquots of 
AM for 48 h  in the presence and absence of serum, respectively. At this point, 
cells that had been initially cultured in serum-containing medium were washed 
and recultured for an additional 48 h in serum-free medium, while cells initially 
cultured in the absence of serum were washed and recultured in serum-contain- 
ing medium. Control cultures containing MEM or MEM supplemented with 5% 
FBS were also cultured for 48 h, at which time the monolayers were washed and 
recuitured in the same medium. The ability of these AM to release H~O~ upon 
triggering with Con A was assessed throughout the culture period. As expected 
(Fig. 5), cells initially cultured in serum-containing medium acquired the ability 
to release ROI; cells cultured in serum-free medium did not.  However, upon 
transfer  to  serum-free medium,  the  serum-conditioned cells  rapidly  lost  the 
TABLE  III 
Inability of LPS to Condition AM  for H~02 Release 
Conditioning agent  Triggering agent 
H202/30 min per 5 X 10  ~ cells 
24 h  48 h  72 h 
nmol 
None  10 t*g/ml Con A  0.8 -4- 0.3  6.1 3= 2.1  4.6 3= 1.9 
5% FBS  10 ~*g/ml Con A  7.9 3= 1.9  24.3 -4- 4.1  25.0 3= 1.7 
0.001 #g/ml LPS  10 t~g]ml Con A  0.8 3= 0.2  6.1 3= 2.2  7.6 3= 3.5 
0.01 #g/ml LPS  10 #g/ml Con A  0.9 3= 0.4  5.3 :t: 2.1  7.6 3= 3.0 
0.1 #g/ml LPS  10 #g/ml Con A  0.9 3= 0.3  6.7 3= 2.5  7.2 3= 2.8 
1.0 #g/ml LPS  10 #g/ml Con A  0.9 +  0.3  5.5 3= 2.3  7.9 3= 3.5 
None  None  0.0 3= 0.0  4.3 3= 1.7  1.9 3= 1.0 
5%FBS  None  0.53=0.2  13.13=1.2  11.33=2.3 
AM  were  conditioned for  24-72  h  with the appropriate  conditioning agents,  triggered with  or 
without  10 #g/ml Con A, and assayed for H~O~ release.  Data represents the mean of nine values 
from three rabbits assayed in triplicate 3= SEM. 400  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
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FIGURE 5.  The  reversible nature of serum  conditioning of AM.  Cells were cultured and 
tested  under three experimental conditions.  (O)  Cells  were  incubated in  serum-containing 
medium for 48 h, washed, and reincubated for an additional 48 h in serum-free medium. (A) 
Cells were incubated in serum-free medium for 48 h, washed, and reincubated for an additional 
48 h  in serum-containing medium. (El) For comparison, a  third (serum control) culture was 
also included, in which cells were incubated in serum-containing medium for 48 h, washed, 
and reincubated for an additional 48 h in serum-containing medium. Arrows indicate time of 
media change. Representative cultures were assayed for H20~ release upon Con A stimulation 
at 0, 24, 48, 72, and 96 h. All experimental values were corrected for HIO~ release, if any, by 
cells maintained throughout in serum-free medium, stimulated with Con A at the appropriate 
time interval.  Results are expressed graphically as the percentage of serum  control values, 
and, in parentheses, as net nmol/30 min per 5 x  108 cells. 
ability to release H202,  whereas cells transferred from serum-free medium to 
serum-containing medium showed a progressive increase in H~O2-releasing ca- 
pacity (Fig. 5). 
In preliminary studies to assess a possible mechanism by which serum enhances 
the amount of ROI released by AM, we examined the NADPH oxidase activity 
of freshly harvested cells as well as cells cultured 48  h  in serum-containing or 
serum-free media. Pretreatment of all cells with  10 mM DDC to inhibit endog- 
enous SOD activity contributed to the sensitivity of the assay. Initial experiments 
with freshly harvested AM showed that PMA-triggered intact cells were routinely 
unable  to  generate  OF.  Also,  lysis  of these  freshly isolated  cells  with  DOC, 
followed by addition  of NADPH,  resulted in  no detectable NADPH  oxidase 
activity (Table IV). Intact cells incubated with 10% FBS for 48 h, however, were 
capable of producing OF when triggered with PMA. When these triggered cells 
were lysed with  DOC  and assayed for NADPH  oxidase activity by adding a 
saturating concentration of NADPH, they continued to produce OF. In contrast, 
the rate of OF production by intact AM incubated in serum-free medium for 48 
h was <20% of that by conditioned AM and, again, no NADPH oxidase activity 
could be detected in lysed cell preparations. The detection of any O~ by intact 
as  well  as  lysed cells  in  these  experiments could  be  totally  inhibited  by  the GERBERICK,  WILLOUGHBY,  AND  WILLOUGHBY  401 
TABLE  IV 
NADPH Oxidase Activity of AM 
O~'/min per 1.0 x  lO  s cells 
Conditioning  Time  DOC-treated cells 
agent  Intact cells  plus 1.2 mM 
NADPH 
h  ~gtlol 
None  0  <0.1  <0.1 
None  48  0.26 +  0.07  <0.1 
10%  FBS  48  1.27 +  0.18  0.80 =!= 0.22 
Freshly harvested AM, and AM cultured 48  h  with or without serum, 
were assayed for O~ production after triggering the intact cells with 1 #g/ 
ml PMA. To assay NADPH oxidase activity we lysed the intact cells with 
DOC and measured the rate of O~ production after addition of 1.2 mM 
NADPH as the substrate. Data represent the mean of three experiments 
+  SEM. 
TABLE ~V 
Cyclohexiraide Inhibition of Serum-conditioning Activity 
Time of cyclo-  H20,/30 min per 
Conditioning agent  heximide addition  5 ×  105 cells 
nraol 
None  --  1.6 +  0.5 
10% FBS  --  19.0  _  1.0 
10% FBS +  0.5 #g/ml CyH  18  13.1  _  1.4 
10% FBS +  1.0 #g/ml CyH  18  5.2 +  0.6 
10% FBS +  0.5 #g/ml CyH  24  19.6 +  0.8 
10% FBS +  1.0 #g/ml CyH  24  20.2 =t: 0.6 
AM were cultured for 24 h  in medium containing 10%  FBS.  Cyclohexi- 
mide (CyH) was added to some cultures at a final concentration of 0.5 or 
1.0 #g/ml at 18 or 24 h. All cultures were then triggered with Con A and 
assayed for H202 release. Data represent the mean of six values from two 
rabbits assayed in triplicate _+ SEM. 
addition of 300 U/ml SOD. In a single experiment using AM from three rabbits 
we determined the Vmax  and Km of NADPH oxidase for serum-conditioned cells 
to be 2.7  nmol/min per  106 cells and 0.57  mM NADPH, respectively. Due to 
the  low  activity of freshly isolated  AM  or  AM  cultured  48  h  in  serum-free 
medium, we were unable to determine a  Vmax  or Km for these cells. 
In  a  separate  study,  we  have  shown  that  the  protein  synthesis  inhibitor, 
cycloheximide, inhibits serum conditioning of rabbit AM for subsequent trig- 
gered ROI release (Table V). In these experiments, AM cultures were incubated 
for 24 h  with  10%  FBS.  In addition, some cultures received 0.5 or  1.0 t~g/ml 
cycloheximide, either at 18 h after culture initiation or just before triggering at 
24 h. These concentrations of cycloheximide have been previously shown (19) 
to inhibit protein synthesis of mouse peritoneal macrophages. All cultures were 
then washed and assayed for their ability to release H~O~ upon Con A triggering. 
The results clearly show that serum-conditioned cells incubated for the final 6 h 
with 0.5 or 1.0 #g/ml cycloheximide released significantly reduced amounts of 
H202 (Table V).  Addition of cycloheximide  just before triggering at 24 h  had 402  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
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FIGURE 6.  Gel filtration of AM-conditioning activity on Sephacryl S-200. Dialyzed fractions 
(1:2  dilution) were  incubated  with  AM for 48  h  before assessment  of Con A  (10  tzg/ml)- 
triggered H~O2 release. The H~O2 generating activity (bars) and A2s0(--) are indicated as well 
as the position of protein markers used in column calibration (4). 
no effect on H202 release. Moreover, incubation of cells with these concentra- 
tions of cycloheximide for 6 h  did not affect the cell number or cell viability as 
determined by dye exclusion. 
Lastly, we undertook initial studies to characterize the component(s) in serum 
responsible for this conditioning effect. Pooled rabbit serum was fractionated as 
outlined in Materials and Methods. The conditioning activity precipitated at 40- 
80% saturated (NH4)~SO4, and did not bind to a Cibacron Blue affinity column. 
Subsequent gel filtration analysis on Sephacryl S-200 revealed a major peak of 
activity with an estimated molecular weight of 30-50 K (Fig. 6). 
Discussion 
The issue of whether AM produce and release ROI is of particular importance 
since these cells are present within the air spaces in large numbers, and are likely 
to come into direct contact with leukocyte-activating agents inhaled from the 
environment (20).  While numerous laboratories (12,  21-23)  have shown that 
stimulated neutrophils and peritoneal macrophages produce and release ROI 
into the extracellular environment, experiments with AM have yielded incon- 
sistent results. For example, while rat and guinea pig AM stimulated by PMA or 
heat-killed E. coli will produce ROI (5-7), freshly isolated rabbit AM release little 
or  no  ROI  when  stimulated  with  zymosan,  opsonized  zymosan,  heat-killed 
bacteria, F-Met-Leu-Phe, or Con A  (8,  24-28).  Similarly, human AM produce 
relatively low levels of ROI relative to that produced by human neutrophils (20, 
30), leading Papermaster-Bender et al. (30) to conclude that an inability of the GERBERICK,  WILLOUGHBY, AND  WILLOUGHBY  403 
AM to produce ROI might protect the lung against inflammatory damage. The 
reported inability of rabbit AM to release ROI has not been absolute, however, 
since they have been shown (8) to release ROI when triggered by Con A or heat- 
killed organisms in the presence of cytochalasin B.  Sugimoto et al.  (9) showed 
that rabbit AM cultured for 24 h in the presence of 10% FBS released ROI after 
addition of cytochalasin B alone. However, the mechanism of action of cytochal- 
asin B  in  these studies is not clear;  it may act by inhibiting internalization of 
membrane segments (31), by increasing the activation of NADPH oxidase (32), 
or by direct stimulation of the cell membrane (9). 
In this paper we show that normal resident rabbit AM are indeed fully capable 
of releasing ROI after stimulation by membrane-active agents after AM have 
been conditioned by culture  in  the presence of 5-10%  serum for  24-48  h. 
Moreover, this  effect appears  to  be due to  a  discrete macromolecular serum 
constituent that precipitates at 40-80%  saturated ammonium sulfate, does not 
bind Cibacron Blue affinity columns, and has an apparent molecular weight of 
approximately 30-50  K.  These findings,  together with the inability of serum 
albumin to condition AM, suggest that such conditioning of AM for ROI release 
is not simply due to a general protein effect. Moreover, our inability to condition 
AM with LPS in the absence of serum further indicates that this serum factor is 
also not due to contaminating endotoxin. 
To ascertain whether such a serum-conditioning requirement was unique for 
normal  rabbit  alveolar  macrophage  ROI  production,  we  have  also  recently 
studied alveolar macrophages from germ-free rats that were confirmed to have 
no pulmonary infections. Like normal rabbit AM, O~ release was demonstrated 
only after these rat AM had been precultured for 48-72 h in 5% FBS (manuscript 
in preparation). 
Evidence exists for a  conditioning action by serum proteins on macrophage 
function. Musson (33) found that human serum induces maturation of human 
monocytes in culture, as assessed by changes in cytolytic activity, intracellular 
lysosomal enzymes, and nonspecific esterase activity. Bianco et ai. (34) described 
two distinct serum factors (one of which appears to be a  low molecular weight, 
complement-derived protein) that cause peritoneal macrophages to spread and 
increase their surface area.  Leonard et al.  (35)  reported that  serum albumin 
caused both  resident and  mouse peritoneal exudate  macrophages to  become 
responsive to chemotactic stimuli. They also described another serum protein, 
which they termed "macrophage-stimulating protein," which enhanced the re- 
sponsiveness of resident peritoneal macrophages to chemotactic stimuli, with a 
molecular weight of 100  K  and a  pI  of 7.0  (35).  Hsueh  et al.  (36)  recently 
reported that both FBS and rabbit serum, but not albumin, stimulate cultured 
rabbit AM to synthesize prostaglandins and release lysosomal enzymes. They also 
observed that, after gel filtration chromatography, the major peak of activity was 
associated with an apparent molecular weight of 150  K.  Chapman and Hibbs 
(37) described a  human serum factor that enhances the tumoricidal capacity of 
peritoneal macrophages, and was found in the last of  three protein peaks obtained 
after passage of whole serum through a Sephadex G-200 column. Finally, data 
published by Johnston et al. (38) suggest that resident mouse peritoneal macro- 404  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
phages  may show  enhanced ROI  release  if they are preincubated in  serum- 
supplemented medium (20%) before stimulation. 
The question arises whether our serum factor is  providing one of the two 
signals  reportedly  required  for  macrophage  ROI  production  (18,  22).  For 
example, muramyl dipeptide (MDP) and LPS have both been shown (18, 22, 39) 
to deliver a  first signal that "primes" peritoneal macrophages, enhancing their 
production of ROI  upon  triggering by the second signal,  PMA or opsonized 
zymosan. Whereas Pabst and Johnston (18) reported that such LPS priming was 
evident within 30  min, in our systems the effect produced by serum required 
24-48  h.  Moreover, we were unable to demonstrate any enhancing action by 
LPS on either resident or serum-conditioned alveolar macrophages, even after 
72 h of incubation. It is noteworthy that previous studies of macrophage priming 
have been carried out, for the most part, in the presence of 10-20% FBS. Thus, 
the priming action of LPS and MDP seems to be distinct from the serum effect 
that we describe; the possibility that MDP replaces or augments the serum effect 
remains untested. 
Of particular  relevance is  the potential  relationship of this serum factor to 
IFN-7,  a  50  K  mol wt glycoprotein produced by activated lymphocytes. Both 
human monocyte-derived macrophages and mouse peritoneal macrophages have 
been shown (40,  41) to be activated by human or mouse IFN-% respectively, 
enhancing their ability to produce ROI upon stimulation with PMA. We feel it 
unlikely that our serum factor is IFN-7 for the following reasons: (a) it seems 
unlikely that normal rabbit serum, pooled human serum, and, in particular, FBS, 
all would contain biologically active concentrations of IFN-~; (b) demonstrations 
of lymphocyte-derived IFN-7  potentiation of ROI  production have been per- 
formed in  the  presence  of  10-20%  serum  (40,  41),  concentrations  that,  by 
themselves, are maximally effective in our assay; (c) our factor retained 67% of 
its activity when held at pH 2.0 for 2 h, whereas IFN-~, is inactivated under these 
conditions (15); (d) while human serum readily conditioned rabbit AM for ROI 
release, human rINF-'y did not at concentrations of 0.01-1000  U/ml. 
Recently, Tsunawaki and  Nathan  (13)  reported that  increased superoxide- 
generating capacity of activated (e.g., NalO4 elicited) vs. resident mouse perito- 
neal macrophages can be attributed to an increase in the affinity of their NADPH 
oxidase  for  its  substrate.  These  investigators found that  the Km  of NADPH 
oxidase was considerably lower for activated cells, whereas the Vmax  of the enzyme 
from activated cells was comparable to that of resident macrophages. In a similar 
study, Sasada et al. (42) reported that LPS-elicited mouse peritoneal macrophages 
contained higher cellular concentrations of NADPH, while their NADPH oxi- 
dase displayed a  higher Vmax  and a  lower Km for NADPH than did the oxidase 
from normal cells. Since both groups of investigators suggested that the enhanced 
oxidative response of activated (or conditioned) macrophages is due, in part, to 
modification of this enzyme responsible for the production of O~-, we looked for 
similar differences between serum-conditioned AM and freshly harvested AM or 
AM cultured in  the absence of serum.  We readily detected NADPH  oxidase 
activity in rabbit AM conditioned with serum-containing medium for 48 h, and 
determined Vmax and Km values of 2.7  nmol/min per  106  cells and 0.57  mM 
NADPH, respectively. On the other hand, cells incubated 48  h  in serum-free GERBERICK,  WILLOUGHBY, AND  WILLOUGHBY  405 
medium or freshly harvested AM showed no detectable NADPH oxidase activity. 
Therefore, it was impossible to determine V~,ax and Km values using these cells. 
The  observed Km  for  serum-conditioned rabbit  AM  was  comparable  to  that 
reported for resident (but ROI producing) mouse peritoneal macrophages (13), 
but  the observed  Vmax  of our cells  was  notably  greater  than  that  of resident 
activated mouse peritoneal cells. 
Our  finding that  the presence of cycloheximide significantly reduces  H~O2 
release by serum-treated cells suggests that protein synthesis is required for the 
serum-conditioning effect. Such protein synthesis is presumably involved in the 
generation  of NADPH  oxidase activity, and  conceivably includes the enzyme 
itself. Moreover, there appears to be a requirement for ongoing protein synthesis, 
since our reversibility experiment shows that serum-conditioned cells transferred 
to serum-free media lose their ability to generate ROI. 
In addition to observing that serum conditions AM for enhanced ROI gener- 
ation upon stimulation, we have confirmed the differential ability of Con A and 
LPS to trigger ROI release. This is of particular interest to us because previous 
studies in our laboratory (43, 44) revealed that Con A, when inhaled repeatedly, 
initiates immune complex formation in the lung, whereas LPS does not, even 
though both are capable of initiating pulmonary interstitial inflammation. The 
mechanism by which Con A initiates immune complex formation is not known; 
it might be mediated in part by stimulation of conditioned AM to release ROI. 
The inability  of LPS to trigger  ROI  production by AM parallels  findings by 
others  using peritoneal  macrophages (16,  17).  This contrasts  with the  highly 
effective triggering by LPS of interleukin  1 release from AM (45),  illustrating 
the differential responsiveness of macrophages to diverse stimuli (22). 
In conclusion, normal resident rabbit AM are notable in that (a) they require 
conditioning by a plasma factor(s) before they can be triggered to release ROI, 
and (b) they do not appear to be primed or triggered by LPS for subsequent 
ROI production. We propose that these properties constitute an inherent pro- 
tective mechanism of the lung against AM-mediated tissue injury, in accord with 
the concept proposed by  Papermaster-Bender  (30).  However,  it  is likely that 
pulmonary inflammatory reactions,  initiated  by  other  mediator  systems,  may 
cause increases in vascular permeability,  with transudation of plasma proteins 
into alveolar  spaces,  thereby  causing  AM  to  become  conditioned in  situ  for 
enhanced generation of ROI. 
Summary 
Alveolar macrophages (AM) from pathogen-free rabbits were unable to release 
reactive oxygen intermediates (ROI) unless they were conditioned in serum for 
24-48  h  before triggering with membrane-active agents. The degree of serum 
conditioning of AM depended upon the concentration of serum used; optimal 
ROI  release  was  obtained  at  or  above  7.5%  fetal  bovine serum  (FBS).  FBS, 
autologous rabbit serum, pooled rabbit serum, and pooled human serum were 
each capable of conditioning AM for release of ROI. Serum conditioning of AM 
requires synthesis of new protein(s); and the enzyme required for ROI produc- 
tion, NADPH oxidase, was only detectable in serum-conditioned cells. Moreover, 
serum-conditioned cells lost their ability to release ROI after transfer to serum- 406  SERUM  CONDITIONING  OF  ALVEOLAR  MACROPHAGES 
free medium, while cells maintained in serum-free medium acquired the capacity 
to release ROI after their transfer to serum-containing medium, demonstrating 
the reversibility of the phenomenon. Initial purification data indicate that con- 
ditioning is  mediated by a  discrete serum constituent, which precipitates 40- 
80% saturated ammonium sulfate, does not bind to Cibacron Blue columns, and 
has  a  molecular  weight  of  30,000  to  50,000,  as  determined  by  molecular 
exclusion chromatography. Unlike gamma interferon, which also enhances ROI 
release by macrophages, our serum-conditioning factor is not acid labile, retain- 
ing 67% of its activity after 120 min incubation at pH 2.0. Moreover, it does not 
appear to be a contaminating endotoxin, since LPS neither conditioned AM for 
ROI production, nor triggered ROI production by serum-conditioned AM. We 
t~ropose  that such a  conditioning requirement may normally protect the lung 
agianst ROI-mediated tissue injury. However, during a pulmonary inflammatory 
reaction initiated by other mediator systems, the resulting transudation of plasma 
proteins into the alveolar spaces may condition AM in situ for ROI production. 
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